Cancer

For the first time, scientists have systematically studied the genetic effects of chemotherapy on healthy tissues.This article was originally published on MedicalXpress.com

While incidence and mortality rates for most cancer types have been on the decline in the United States, cases of uterine cancer increased an average of 0.7% each year between 2013 and 2022 and age-adjusted […]

Scientists at the National Institutes of Health (NIH) have found that two common types of hormone therapy may alter breast cancer risk in women before age 55. The study, “Hormone therapy use and young-onset breast […]

Oncologists utilizing artificial intelligence (AI) in their tests to spot pancreatic cancer at an early stage can also gain an overall picture of how the deadly disease is bound to develop, scientists from the University […]

Three major Mount Sinai research studies offer new hope for patients facing chronic lymphocytic leukemia (CLL), a rare type of blood cancer. The studies were led by Adam Kittai, MD, Associate Professor of Medicine (Hematology […]

Cancer is costly for patients and the NHS—but it also has a significant impact on the U.K. economy, according to research led by the University of Leeds.This article was originally published on MedicalXpress.com

Breast cancer is one of the most common cancers among women in the United States. Thanks to decades of fundamental research, it’s also one of the most curable. The exception is a particularly aggressive variant […]

In the fight against cancer, immunotherapy—which aims to boost the body’s natural defenses against cancer—is experiencing remarkable growth. Most of these treatments are based on CD8 T lymphocytes, “killer cells” able to eliminate diseased cells. […]

Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with resectable locally advanced head and neck squamous cell carcinoma whose tumors express PD-L1 […]

Immunotherapy has revolutionized cancer treatment by mobilizing the immune system to attack tumor cells. Major advances, such as immune checkpoint inhibitors (notably against the PD-1 protein), have produced impressive results against certain types of cancer, […]